Monthly Archives: September 2017

Study: Preventive infection-fighting drugs can cut deaths in people starting HIV treatment late

By on .

In the era of World Health Organization guidelines recommending immediate antiretroviral treatment for people with HIV before the disease progresses, the reality in sub-Saharan Africa remains that up to 25 percent of patients who show up at clinics show up with extremely advanced illness, and that about 10 percent of them die soon after starting […]

What we’re reading: Leahy on HIV funding, Global Gag Rule costs, and equalizing access to preferred medicines

By on .

While awaiting appropriations decisions that will establish the public health priorities and capacities for responding to infectious diseases at home and in countries around the world over the coming year, questions include how available moneys can be put to the most effective use. This week we’re reading about both policies and strategies that  make a […]

Who needs infectious disease docs? Everyone . . .

By on .

Journal supplement delves into the rewards and challenges of chasing bugs no one wants to catch . . . Of all the specialties a young physician can enter, one that offers a career of saving lives and protecting communities, supporting social justice and alleviating suffering, while following questions and finding answers across health systems, neighborhoods […]

WHO report highlights need for new TB drugs

By on .

 “An analysis of the antibacterial clinical development pipeline, including tuberculosis” finds development falling short especially for tuberculosis . . . Report finds second-line treatment regimens for TB already compromised, evidence of increasing transmission of multi, extensively drug-resistant TB, while lack of economic incentives continue to stall new tuberculosis drug development . . .     […]

State Department, PEPFAR release good news and a “strategy” short on details, definition

By on .

Names 13 countries for “particular focus” with aim for epidemic control by 2020 . . . Botswana, Côte d’Ivoire, Haiti, Kenya, Lesotho, Malawi, Namibia, Rwanda, Swaziland, Tanzania, Uganda, Zambia, Zimbabwe to be focus of efforts . . . Providing some clarification to proposals to shift the focus of the President’s Emergency Plan for AIDS Relief […]

Study suggests opening use of last resort TB drug for children

By on .

Researchers: bedaquiline can be used safely in MDR TB patients 12 and older, and should be considered for younger children The innovative anti-tuberculosis drug that represents a reprieve for adults whose disease does not respond to other treatments should also be made available to children aged 12 or older, according to findings from a study […]

What we’re reading: Insights on global health policy, and why, when funding doesn’t support disease-fighting goals, something’s got to give

By on .

Goalkeepers: The stories behind the data – A companion piece to the data-dense Lancet review of health-related goals for 2030  released Tuesday, the stories behind the data told here focus on policies and practices that are pushing progress — through patient-focused health services, targeted use of new technologies, and greater investments — now. While acknowledging […]

Global health data review finds no country on track to end TB incidence by 2030, vast majority of countries falling short of goals to control HIV

By on .

Projections based on  current burdens of disease, along with data from the preceding 26 years, show both vast inequalities of progress, as well as the likelihood of limited success across both wealthy and low-income countries in meeting specific goals to improve health care and health access around the world by 2030. The projections from a […]

Appropriators approve sustained global health, boost to TB, increased research funding, reject expanded global gag rule

By on .

“Now is not the time to back off,” Sen. Lindsay Graham (R-SC) Senate appropriators today approved spending for the coming fiscal year that would continue current funding levels for global health programs, add $2 billion to funding for the National Institutes of Health, including by maintaining the Fogarty International Center and its worldwide research and […]